Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Acute Coronary Syndrome Accelerated CardioFlux TM Magnetocardiography-based Early Disposition Study

NCT04739267 is registered in ClinicalTrials.gov with Genetesis Inc. as lead sponsor.

NCT NCT04739267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04739267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Acute Coronary Syndrome Accelerated CardioFlux TM Magnetocardiography-based Early Disposition Study
Lead sponsor
Genetesis Inc.
Phase
Observational
Overall status
Completed
Start date
January 27, 2021
Completion date
March 3, 2023
Enrollment
390 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial injuries